Patent details

EP1827500 Title: PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743

Basic Information

Publication number:
EP1827500
PCT Application Number:
PCT/GB/2005/050189
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP058031519
PCT Publication Number:
WO/2006/046080
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743
French Title of Invention:
DOXORUBICINE LIPOSOMIALE PEGYLEE EN COMBINAISON AVEC L' ECTEINESCIDINE 743
German Title of Invention:
PEGYLIERTES LIPOSOMALES DOXORUBICIN IN KOMBINATION MIT ECTEINESCIDIN 743
SPC Number:

Dates

Filing date:
26/10/2005
Grant date:
06/05/2009
EP Publication Date:
06/05/2009
PCT Publication Date:
04/05/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2007
EP B1 Publication Date:
06/05/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/10/2025
Renunciation date:
Revocation date:
04/10/2016
Annulment date:

Owner

From:
26/10/2005
 
 

Name:
Ortho Biotech Products L.P.
Address:
700 Us Highway 202, Raritan NJ 08869, United States (US)

Name:
Pharma Mar S.A. Sociedad Unipersonal
Address:
Polígono Industrial La Mina Avda. de los Reyes, 1 Colmenar, 28770 Madrid, Spain (ES)

Agent

Name:
MARKS & CLERK LLP
From:
13/05/2009
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
STERNAS Lars-Axel
Address:
United States (US)

2

Name:
VAN DE VELDE Helgi
Address:
Belgium (BE)

3

Name:
GILLES Erard
Address:
United States (US)

4

Name:
TEITELBAUM April
Address:
United States (US)

5

Name:
TRIFAN Ovid
Address:
United States (US)

Priority

Priority Number:
622163 P
Priority Date:
26/10/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 47/48;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2017/01
Publication date:
16/03/2017
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
201708
Publication date:
22/02/2017
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/10/2016
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56